A Double Blind, Randomized, Cross-over Study Examining the Suppression of the Photoparoxysmal EEG Response With NPT 2042

NCT06525649 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

5

Enrollment

INDUSTRY

Sponsor class

Conditions

Photosensitive Epilepsy
Epilepsy

Interventions

DRUG: NPT 2042

Sponsor

NeuroPro Therapeutics, Inc.

Collaborators

[object Object]